Evaluation of anti-tumorigenic activity of BP3B against colon cancer with patient-derived tumor xenograft model.

BMC Complement Altern Med · 2016 · PMC5116142 · PMID 27863496

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The increase in median survival from 14.7 to 16.2 months did not reach statistical significance [ 6 ].

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.